Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony C Gordon

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Intensive Care Medicine|May 8, 2015
What's new in vasopressin?D J P O'Callaghan, Anthony C Gordon
JAMA|February 26, 2021
Emerging Lessons From COVID-19 for the US Clinical Research EnterpriseDerek C Angus, Anthony C Gordon, Howard Bauchner
American Journal of Respiratory and Critical Care Medicine|February 2, 2019
Early May Be Better: Early Low-Dose Norepinephrine in Septic ShockJames A Russell, Anthony C Gordon, Keith R Walley
The New England Journal of Medicine|February 23, 2017
Levosimendan in SepsisAnthony C Gordon, Robert M L Orme, Mervyn Singer
Critical Care Medicine|August 17, 2023
Adverse Effects of Tocilizumab Versus Baricitinib in Severe COVID-19David E Leaf, Anthony C Gordon, Patrick R Lawler
Critical Care Medicine|January 21, 2006
Are vasopressin levels increased or decreased in septic shock?Ainsley M Sutherland, Anthony C Gordon, James A Russell
The New England Journal of Medicine|August 18, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. ReplyAnthony C Gordon, Derek C Angus, Lennie P G Derde
Intensive Care Medicine|January 11, 2023
The effect of vasopressin and hydrocortisone on cytokine trajectoriesCharlotte Cleasby, Tim Marshall, Anthony C Gordon, et al.
Journal of the Intensive Care Society|October 6, 2017
Comparative safety and efficacy of vasopressors for mortality in septic shock: A network meta-analysisMyura Nagendran, Mahiben Maruthappu, Anthony C Gordon, et al.
The Journal of Infectious Diseases|October 16, 2025
Platform Trials to Assess Therapeutics in Patients Hospitalized With InfluenzaAlicia A C Waite, Leon Peto, Anthony C Gordon, et al.
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Intensive Care Medicine|May 8, 2015
What's new in vasopressin?D J P O'Callaghan, Anthony C Gordon
JAMA|February 26, 2021
Emerging Lessons From COVID-19 for the US Clinical Research EnterpriseDerek C Angus, Anthony C Gordon, Howard Bauchner
American Journal of Respiratory and Critical Care Medicine|February 2, 2019
Early May Be Better: Early Low-Dose Norepinephrine in Septic ShockJames A Russell, Anthony C Gordon, Keith R Walley
The New England Journal of Medicine|February 23, 2017
Levosimendan in SepsisAnthony C Gordon, Robert M L Orme, Mervyn Singer
Critical Care Medicine|August 17, 2023
Adverse Effects of Tocilizumab Versus Baricitinib in Severe COVID-19David E Leaf, Anthony C Gordon, Patrick R Lawler
Critical Care Medicine|January 21, 2006
Are vasopressin levels increased or decreased in septic shock?Ainsley M Sutherland, Anthony C Gordon, James A Russell
The New England Journal of Medicine|August 18, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. ReplyAnthony C Gordon, Derek C Angus, Lennie P G Derde
Intensive Care Medicine|January 11, 2023
The effect of vasopressin and hydrocortisone on cytokine trajectoriesCharlotte Cleasby, Tim Marshall, Anthony C Gordon, et al.
Journal of the Intensive Care Society|October 6, 2017
Comparative safety and efficacy of vasopressors for mortality in septic shock: A network meta-analysisMyura Nagendran, Mahiben Maruthappu, Anthony C Gordon, et al.
The Journal of Infectious Diseases|October 16, 2025
Platform Trials to Assess Therapeutics in Patients Hospitalized With InfluenzaAlicia A C Waite, Leon Peto, Anthony C Gordon, et al.
Pageof 15